Neurontin Michele Norris talks with NPR's Snigdha Prakash about actions by drug company Parke-Davis to promote the drug Neurontin for uses not yet approved by the government. NPR has obtained documents indicating that Tony Wild, then-president of Parke-Davis, was aware of the plan to work around FDA approval to promote the drug.

Neurontin

Neurontin

  • Download
  • <iframe src="https://www.npr.org/player/embed/885153/885154" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Michele Norris talks with NPR's Snigdha Prakash about actions by drug company Parke-Davis to promote the drug Neurontin for uses not yet approved by the government. NPR has obtained documents indicating that Tony Wild, then-president of Parke-Davis, was aware of the plan to work around FDA approval to promote the drug.